VolitionRx pays off $7.5M convertible note early
VolitionRx fully repays a $7.5 million convertible note early, removing a source of potential dilution while leaving $2.04 million outstanding on a separate Lind facility.
Rhea-AI Filing Summary
VolitionRx Limited (VNRX) has fully prepaid in cash its senior secured convertible promissory note issued to Lind Global Asset Management XII LLC, originally for $7.5 million and due May 20, 2027, eliminating all obligations under that note and reducing potential equity overhang from future conversions. A second senior secured convertible promissory note issued to Lind on January 7, 2026, with an original principal amount of $2.4 million, remains outstanding in the amount of $2,041,667. Management states that further debt and expense reduction remains a top priority.
Positive
- $7.5 million senior secured convertible note has been fully prepaid in cash, eliminating related obligations and reducing potential dilution from conversions.
- Management highlights ongoing focus on debt and expense reduction, signaling continued efforts to strengthen the company’s financial position.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 8.01, 9.01
2 items
Item 8.01
Other Events
Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Repaid senior secured convertible note principal: $7,500,000
Maturity date of repaid note: May 20, 2027
Second note original principal: $2,400,000
+1 more
4 metrics
Repaid senior secured convertible note principal
$7,500,000
Original principal amount of the note prepaid in full
Maturity date of repaid note
May 20, 2027
Original due date of the $7.5 million note, prepaid more than eight months early
Second note original principal
$2,400,000
Original principal of the remaining senior secured convertible note to Lind
Second note outstanding balance
$2,041,667
Remaining amount outstanding on the January 7, 2026 senior secured convertible note
Key Terms
senior secured convertible promissory note, equity overhang, NETosis, forward-looking statements
4 terms
senior secured convertible promissory note financial
"the full pre-payment in cash of the outstanding balance on its senior secured convertible promissory note"
A senior secured convertible promissory note is a formal IOU a company issues that is backed by specific assets (secured), given higher priority for repayment than other debts (senior), and can be exchanged for company shares instead of cash (convertible). For investors this means the loan is safer than unsecured debt because it has collateral and repayment priority, but it also carries the potential for dilution if the lender converts the note into equity — like holding a mortgage-backed IOU that can later be swapped for ownership stakes.
equity overhang financial
"Pre-Payment in Full of $7.5 million Senior Secured Convertible Promissory Note ... Reduces Equity Overhang"
Equity overhang is the presence of a large number of shares that exist on paper or can be created in the future—such as stock options, convertible bonds, or reserved shares—that may be sold or converted into common stock and increase the total share count. Investors watch it because those extra shares can reduce each owner’s slice of the company and put downward pressure on the stock price, like adding more people to a pie-splitting table and shrinking each person’s piece.
NETosis medical
"including some cancers and diseases associated with NETosis, such as sepsis"
Netosis is a process where a type of white blood cell ejects a sticky web-like mesh to trap germs, sacrificing itself in the process. While intended as a protective response, these nets can also spark inflammation, blood clots or tissue damage, so they matter to investors because drugs that alter netosis can become new therapies or safety risks, affect clinical trial outcomes, and influence regulatory and market value for companies working on related diagnostics or treatments.
forward-looking statements regulatory
"Statements in this press release may be "forward-looking statements" within the meaning of Section 27A"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What debt did VolitionRx (VNRX) just repay?
VolitionRx fully prepaid in cash its senior secured convertible promissory note issued to Lind Global Asset Management XII LLC, originally for $7.5 million and due May 20, 2027, and states that all obligations under this note have been satisfied.
What debt to Lind remains outstanding for VolitionRx (VNRX)?
A second senior secured convertible promissory note dated January 7, 2026, originally for $2.4 million, remains outstanding to Lind in the amount of $2,041,667, according to the company’s disclosure.
What financial strategy does VolitionRx (VNRX) emphasize in this announcement?
VolitionRx’s CEO states the company is executing its plan to improve its financial position and that further debt and expense reduction remains a top priority as it seeks to maximize stockholder value.
What type of instrument was the repaid VolitionRx note?
The repaid instrument was a senior secured convertible promissory note with an original principal of $7.5 million, giving the lender potential conversion rights into equity prior to its prepayment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
